Healthcare

News
|

FDA increases efforts to tackle illegal animal drug sales

The move is part of the agency's mission to increase the availability of safe, effective animal drugs.
E-BOOK SPECIAL REPORT
44 Best Package Designs: 2015
Sign up to receive timely updates from our editors and download this e-book of our editors’ selections for most innovative package designs of the past year.
News
|

Is lack of standardized medical device labeling harming patients?

The FDA is studying if they should require standardized medical device labeling.

Novartis package features child-resistant design

Novartis Exforge HCT, for treating high blood pressure, is packaged by PCI, using the MWV Shellpak Renew child-resistant design to support patients in taking their daily medication.

Eli Lilly compliance pack earns honors

The 2014 HCPC Compliance Package of the Year First Runner Up was awarded to the Eli Lilly Strattera® Physician Sample Pack from PCI, which contains medication for the treatment of attention-deficit/hyperactivity disorder (ADHD).

HCPC Compliance Package of the Year

Astra Zeneca’s SEROQUEL XR® 14-Day Sample Kit for Acute Bipolar Depression is in a calendarized blister pack from MWV that promotes patient adherence for this medication’s complex dosing regimen.
MaxStick Products: Adhesive labels
Materials Product Brief
|

MaxStick Products: Adhesive labels

MaxStick Spectrum Packaging offers all seven colors of liner-free labels in one carton
News
|

Near record lows for medical device recalls

It's been two years since the FDA saw recall numbers this low.
UL is a global independent safety science company that has championed progress for 120 years.
News
|

Verification program and new mark for dietary supplements

UL Consumer Products launches UL Verification Mark in response to growing industry need for third-party verification of marketing claims.
•	2014 HCPC Compliance Package of the Year: Astra Zeneca SEROQUEL XR® 14-Day Sample Kit for Acute Bipolar Depression from MWV.
Feature Article
|

Astra Zeneca, Eli Lilly, Novartis win HCPC honors

The Healthcare Compliance Packaging Council unveils the most innovative pharmaceutical packages designed to improve patient adherence.
FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids
News
|

FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids

The U.S. Food and Drug Administration on April 1, 2015 issued a final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.

Pages

Subscribe to Healthcare

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
PACKAGING MACHINERY
SPECIAL INTEREST
PACK EXPO
Each newsletter ranges in frequency from once per month to a few times per month at most.